Dr. Negroski is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5741 Bee Ridge Rd
Ste 530
Sarasota, FL 34233Phone+1 941-487-2160Fax+1 947-487-2170
Summary
- Dr. Donald Negroski is a neurology specialist located in Sarasota, FL, with sub-specialties in neuroimmunology and multiple sclerosis. He completed his neurology residency at Cleveland Clinic Foundation and graduated from The University of Toledo College of Medicine in 1981. Dr. Negroski currently practices at Negroski Neurology and serves as Director at the Multiple Sclerosis Center of Sarasota. His expertise includes general neurology with focus on Multiple Sclerosis. He has contributed to several publications on multiple sclerosis and has been involved in clinical trials.
Education & Training
Cleveland Clinic FoundationResidency, Neurology, 1981 - 1985
The University of Toledo College of MedicineClass of 1981
Certifications & Licensure
FL State Medical License 1985 - 2026
American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- Top 1% American Most Honored Doctors American Registry, 2021-2022
- Sarasota Magazine: Top Doctors Castle Connolly, 2004-2022
- CMS Meaningful Use Stage 1 Certification Acumen nEHR, Health IT Services Group, 2012-2013
- Join now to see all
Clinical Trials
- Study of Fampridine-ER Tablets in Patients With Multiple Sclerosis Start of enrollment: 2011 Mar 01
Publications & Presentations
PubMed
- 8 citationsDiroximel fumarate in patients with relapsing-remitting multiple sclerosis: Final safety and efficacy results from the phase 3 EVOLVE-MS-1 study.Barry A Singer, Douglas L Arnold, Jelena Drulovic, Mark S Freedman, Ralf Gold
Multiple Sclerosis. 2023-12-01 - 3 citationsEffectiveness and safety of switching to teriflunomide in older patients with relapsing multiple sclerosis: A real-world retrospective multicenter analysis.Regina Berkovich, Donald Negroski, Daniel Wynn, Daniel Sellers, Kristen G Bzdek
Multiple Sclerosis and Related Disorders. 2023-02-01 - Correction to: Communicating the relevance of neurodegeneration and brain atrophy to multiple sclerosis patients: patient, provider and researcher perspectives.Penny Pennington, Bianca Weinstock-Guttman, Channa Kolb, Dejan Jakimovski, Katherine Sacca
Journal of Neurology. 2023-02-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
